Pfizer Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
Pfizer Q2 2024 Adj. EPS $0.60 Beats $0.46 Estimate, Sales $13.283B Beat $13.024B Estimate
Pfizer Expects 2024 Sales Of $59.5B-$62.5B Compared To Prior Guidance Of $58.5B-$61.5B And Consensus Of $60.668B